Skip to content
MARKETS / NASDAQ / SGRY
NASDAQ · SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC · LARGE CAP

Surgery Partners, Inc. SGRY

12 fiscal years on record · USD · FY2025 reported · SEC filings only
$3.3B
▲ 6.2% YoY
$-77.9M
$195.6M
▼ 6.7% YoY
In brief

What this company does

Surgery Partners, Inc. owns and operates a national network of surgical facilities and ancillary services. As of December 31, 2025, the company owned or operated 176 surgical facilities, including 157 ASCs and 19 licensed surgical hospitals. Patient services provided in its ASCs and surgical hospitals generated approximately $3.2 billion in revenue during 2025. As of December 31, 2025, the company had approximately 16,000 full-time and part-time employees. During 2025 and 2024, the company operated in one reportable segment, Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. Its surgical facilities primarily provide non-emergency surgical procedures across specialties including orthopedics and pain management, ophthalmology, gastroenterology and general surgery.

Written from the business description in Surgery Partners, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 2 March 2026. Every sentence was checked against that document before publication.

Growth
USD 3.3B
Revenue, FY2025 · full 12-year series below
Revenue $B Net income $B
FY2025 · Revenue 3.3 · Net income -0.1
2B2013201520182020202220242025
Compound annual growth
+9.2%
+12.2%
+13.2%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +12.2% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
3 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 11.8% · Net 3.0%
10%20%-2%-4%-6%2013201520182020202220242025
ROE
FY2025 · ROE -4.4%
100%200%300%-20%-40%2013201520182020202220242025

Each USD of equity lost 4 cents this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 195.6
80M160M2013201520182020202220242025
Net buybacks $M Dividends $M
FY2020 · Dividends — · Net buybacks 0.0
2M2013201420152016201820192020

Total assetsUSD 8.1B
EquityUSD 1.7B
CashUSD 239.9M
Gross debtUSD 3.7B
Net debtUSD 3.5B
Current ratio1.87×

Net debt stands at 204% of equity.

The 12-year record
12 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 202520242023202220212020201920182016201520142013
Revenue $B3.33.12.72.52.21.91.81.81.11.00.40.3
Operating income $B0.40.30.30.30.30.20.20.10.20.10.10.1
EBITDA $B0.60.50.40.50.40.30.30.10.20.20.10.1
Income tax $B0.00.1−0.00.00.0−0.00.00.00.0−0.10.00.0
Net income $B−0.1−0.2−0.0−0.1−0.1−0.1−0.1−0.20.00.0−0.1−0.0
Free cash flow $B0.20.20.20.10.00.20.10.10.10.10.00.0
EPS, diluted $−0.61−1.33−0.09−0.59−1.12−3.19−2.29−4.960.200.04−2.04−0.28
Dividend / sh $············
Payout %············
ROE %−4.4−8.9−0.6−3.5−11.8−56.3−21.3−38.8334.7···
Shares out B0.130.130.130.130.090.050.050.050.050.050.00·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 49 reconciliationsAUDITED

Reconciled in 13 of 19 fiscal years. 40 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-General Medical & Surgical Hospitals, NEC
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2013

Share this section

Download image